Position
Creative Planning in Fate Therapeutics Inc
Back to the book · All holders of FATE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $5.19K$0.98 → $1.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 23.9K | $23.5K | — | — | — | 0.0% |
| Q1 2026 | 49.4K | $59.3K | $1.20 | $5.19K | $30.6K | 0.0% |